VHL mutations occur in approximately 50% of sporadic ccRCC, which prevent the VHL-mediated degradation of the hypoxia-inducible factor (HIF)α under normoxic conditions. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.